Phillip Kang

424 total citations
15 papers, 342 citations indexed

About

Phillip Kang is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Phillip Kang has authored 15 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Public Health, Environmental and Occupational Health, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Phillip Kang's work include IL-33, ST2, and ILC Pathways (4 papers), Opioid Use Disorder Treatment (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Phillip Kang is often cited by papers focused on IL-33, ST2, and ILC Pathways (4 papers), Opioid Use Disorder Treatment (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Phillip Kang collaborates with scholars based in United States, Cyprus and India. Phillip Kang's co-authors include Sergei P. Atamas, Irina G. Luzina, Virginia Lockatell, Nevins W. Todd, Sanjay Kumar, David V. Schaffer, Edward M. Pickering, Allen Burke, Jeffrey D. Hasday and Ashish Nagarsekar and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Molecular Biology of the Cell.

In The Last Decade

Phillip Kang

12 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Phillip Kang United States	7	181	115	95	64	42	15	342
Robin Z. Cheng United States	7	356 2.0×	57 0.5×	43 0.5×	98 1.5×	21 0.5×	7	509
Erika Conforti Italy	11	72 0.4×	80 0.7×	27 0.3×	168 2.6×	72 1.7×	14	330
Noëmie Pörtner Belgium	11	133 0.7×	37 0.3×	39 0.4×	127 2.0×	34 0.8×	21	319
Rustam Bagirzadeh United States	8	71 0.4×	37 0.3×	119 1.3×	114 1.8×	24 0.6×	11	301
Zeshan Tariq United States	6	215 1.2×	60 0.5×	47 0.5×	251 3.9×	78 1.9×	9	587
John Snowball United States	13	51 0.3×	123 1.1×	232 2.4×	194 3.0×	26 0.6×	24	451
Géraldine Descamps Belgium	16	203 1.1×	108 0.9×	108 1.1×	156 2.4×	82 2.0×	23	671
Xiaosong Chen China	8	93 0.5×	37 0.3×	83 0.9×	194 3.0×	13 0.3×	14	377
Hong Pan China	10	56 0.3×	36 0.3×	35 0.4×	81 1.3×	55 1.3×	22	376
Daiki Yoshii Japan	11	123 0.7×	137 1.2×	61 0.6×	70 1.1×	50 1.2×	41	367

Countries citing papers authored by Phillip Kang

Since Specialization

Citations

This map shows the geographic impact of Phillip Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Kang more than expected).

Fields of papers citing papers by Phillip Kang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Kang. The network helps show where Phillip Kang may publish in the future.

Co-authorship network of co-authors of Phillip Kang

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Kang. A scholar is included among the top collaborators of Phillip Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Kang. Phillip Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Kang, Phillip, Christiane Wolf, Varghese Thomas, et al.. (2025). Urine methamphetamine-to-amphetamine ratio by LC-MS/MS to differentiate methamphetamine use from pharmaceutical impurity in patients prescribed amphetamine. PubMed. 37. 49–55. 1 indexed citations

Tolan, Nicole V., Phillip Kang, Peter R. Chai, et al.. (2024). Impact of COVID-19 on Drug Positivity Rates in the Emergency Departments in Boston and Surrounding Areas. The Journal of Applied Laboratory Medicine. 9(6). 1064–1070.

Kang, Phillip, et al.. (2024). Clinical performance of a new lateral flow immunoassay for xylazine detection. Clinical Chemistry and Laboratory Medicine (CCLM). 63(4). 764–770. 2 indexed citations

Yusufov, Miryam, et al.. (2024). Clinician Ordering and Management Patterns of Urine Toxicology Results at a Cancer Center. Journal of Pain and Symptom Management. 68(1). e36–e45.

Tolan, Nicole V., et al.. (2024). Despite the improved clinical sensitivity of the Roche benzodiazepines II assay it cannot replace mass spectrometry in all patient populations. SHILAP Revista de lepidopterología. 33. 14–20. 2 indexed citations

Uljon, Sacha, Nicole V. Tolan, Grace K. Mahowald, et al.. (2024). Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl. The Journal of Applied Laboratory Medicine. 9(5). 895–904. 1 indexed citations

Genzen, Jonathan R., et al.. (2023). Robust Response of the Clinical Laboratory to the COVID-19 Pandemic despite Significant Challenges. The Journal of Applied Laboratory Medicine. 8(6). 1160–1172.

Luzina, Irina G., Virginia Lockatell, Rita Fishelevich, et al.. (2022). Full-length IL-33 augments pulmonary fibrosis in an ST2- and Th2-independent, non-transcriptomic fashion. Cellular Immunology. 383. 104657–104657. 6 indexed citations

Kang, Phillip, David V. Schaffer, & Sanjay Kumar. (2020). Angiomotin links ROCK and YAP signaling in mechanosensitive differentiation of neural stem cells. Molecular Biology of the Cell. 31(5). 386–396. 33 indexed citations

10.

Smith, P. Brian, Daniel K. Benjamin, Kanecia O. Zimmerman, et al.. (2020). Early-onset sepsis in term infants admitted to neonatal intensive care units (2011–2016). Journal of Perinatology. 41(1). 157–163. 25 indexed citations

11.

Kang, Phillip, Sanjay Kumar, & David V. Schaffer. (2017). Novel biomaterials to study neural stem cell mechanobiology and improve cell-replacement therapies. Current Opinion in Biomedical Engineering. 4. 13–20. 17 indexed citations

12.

Luzina, Irina G., Virginia Lockatell, Sang Won Hyun, et al.. (2016). Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis. American Journal of Physiology-Lung Cellular and Molecular Physiology. 310(10). L940–L954. 39 indexed citations

13.

Luzina, Irina G., Virginia Lockatell, Phillip Kang, et al.. (2013). Interleukin-33 Potentiates Bleomycin-Induced Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 49(6). 999–1008. 106 indexed citations

14.

Luzina, Irina G., Virginia Lockatell, Edward M. Pickering, et al.. (2012). Natural production and functional effects of alternatively spliced interleukin-4 protein in asthma. Cytokine. 58(1). 20–26. 19 indexed citations

15.

Luzina, Irina G., Edward M. Pickering, Phillip Kang, et al.. (2012). Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion. The Journal of Immunology. 189(1). 403–410. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact